Search for

 

1213 results found

Clinical & Regulatory Cannabinoid Research Conference

In an industry first event the CMC has drawn together a roster of political, scientific and public policy leaders to illuminate current research and regulatory opportunities and challenges in the use of cannabis-based medicinal products (CBMPs).

Professor Sir Mark Caulfield

Professor Sir Mark Caulfield is Professor of Clinical Pharmacology at Queen Mary University of London and the CEO of Barts Life Sciences , a research and innovation partnership between Queen Mary University of London and Barts Health NHS Trust.  From January 2022 he is Vice P...

Strengthening the foundations of clinical pharmacology​

A review of the MBBS Clinical Pharmacology Curriculum was coordinated by the Education and Training and Clinical Committees. Led by the Deputy Vice President (Clinical) Dr Dagan Lonsdale, this review will ensure the curriculum reflects changes in clinical pharmacology prac...

House of Lords evidence session highlights the role of clinical pharmacology in healthy ageing

The UK Government has adopted increasing health span as a policy objective in its Industrial Strategy “ Ageing Society” Grand Challenge , which aims to ensure that people can enjoy at least 5 extra healthy, independent years of life by 2035. In July 2019, The House of Lords S...

Integrative technologies in precision medicine

From the latter end of the twentieth century we have seen an unprecedented bench-to-clinic transition of novel medicines in the clinical management of a diversity of pathologies. With such a rapid expansion in the pharmacological toolbox, evidence of population heterogeneity ...

How you can help

Supporting the COVID-19 effort We’re aware that many of our members are supporting the efforts in lots of different ways, from clinical members on the front line to members sharing their expertise with policy makers to help drive decision making. If you’d like to know how yo...

Affinity groups update

The Drug Discovery, Development & Evaluation (DDDE) Affinity Group aims to support members of the Society with interests in all aspects of pharmacology from drug discovery to prescribed use including target identification, drug development, safety pharmacology, conduct of med...

BPS Assessment - Training Solutions

About BPS Assessment BPS Assessment is the commercial assessment and eLearning arm of the British Pharmacological Society. Its mission - to drive improvement in medication safety through knowledge, assessment, and learning - has propelled the launch of multiple training pr...

BJCP article: Standardised assessment evaluates medical students’ competence at prescribing medicati

A new study describes a standardised assessment that ensures that students who graduate from UK medical schools have achieved a minimum standard of knowledge and skill related to prescribing medications. Following the introduction of the Prescribing Safety Assessment , as des...

Introducing the Early Career Pharmacologists supporting WCP2023

  In July, the Society will host the 19th World Congress of Basic and Clinical Pharmacology (WCP2023) . The event, which will take place 2-7 July in Glasgow, Scotland, will deliver an exciting programme that celebrates pharmacology at all levels and across all disciplines....